Cargando…
Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects
Obesity related hypertension is a major risk factor for resistant hypertension. We do not completely understand the mechanism(s) underlying the development of obesity related hypertension which hinders the development of novel treatment strategies for this condition. Data from experimental studies a...
Autores principales: | Giam, Beverly, Kuruppu, Sanjaya, Head, Geoffrey A., Kaye, David M., Rajapakse, Niwanthi W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924205/ https://www.ncbi.nlm.nih.gov/pubmed/27314383 http://dx.doi.org/10.3390/nu8060364 |
Ejemplares similares
-
Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice
por: Rajapakse, Niwanthi W., et al.
Publicado: (2015) -
Pharmacological hypothesis: Nitric oxide‐induced inhibition of ADAM‐17 activity as well as vesicle release can in turn prevent the production of soluble endothelin‐converting enzyme
por: Kuruppu, Sanjaya, et al.
Publicado: (2017) -
N‐acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
por: Giam, Beverly, et al.
Publicado: (2016) -
Insulin-Mediated Activation of the L-Arginine Nitric Oxide Pathway in Man, and Its Impairment in Diabetes
por: Rajapakse, Niwanthi W., et al.
Publicado: (2013) -
Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
por: Nomura, Haru, et al.
Publicado: (2022)